Armin is a specialist for laboratory medicine and infectious diseases from Augsburg, Germany. He has been working in the field of diagnostic tests for Borrelia burgdorferi and coinfections for more than 20 years. Armin has tested more than 50,000 patients for different tick-borne diseases and multiple infections.
Having acquired a broad range of expertise, Dr. Schwarzbach recognized the problem of insensitivities and lacking standardization with regard to Borrelia burgdorferi antibody ELISA- and immunoblot-tests. He accomplished this by comparing these test results with the patients’ typical symptoms for Lyme disease.
Dr. Schwarzbach is member of the German Borreliosis Society, the Swiss Association for Tick-borne diseases, the German Association of Clinical Chemistry and Laboratory Medicine, the German Society for Medical Laboratory Specialists (DGKL) and the Australasian Integrative Medicine Association.
Dr. Schwarzbach presented at Lyme Disease Forum, Houses of Parliament, London, England.
Dr. Schwarzbach was invited by the Joint Committee on Health and Children, Dublin, Ireland regarding prevention and treatment of Borreliosis.Read More
Together with seven other European partners from Spain, Italy, Portugal, Finland, and Belgium, Dr. Schwarzbach took part in the FP7 scientific research program of the European Union, regarding the Hilysens project from 2011-2013. The aim of this project was to develop a prototpye in form of a highly sensitive laboratory on a chip system for Borrelia burgdorferi IgG and IgM antibodies.
He was member of the working group for Lyme disease of the Haut Conseil de la santé publique, Paris, France, and of the working group for Lyme Disease Think Tank, British Columbia’s Women’s Hospital Complex Chronic Disease Program, Vancouver, Canada.Read More
Dr. Schwarzbach was member of the Chief Medical Officer’s Clinical Advisory Committee on Lyme Disease in Australia (CACLD) of the Australian Government, Department of Health and Ageing, Canberra, Australia.Read More
By 1993 he had started specializing in laboratory medicine for another four years in infectiology, microbiology, immunology, hematology, clinical chemistry, endocrinology and gynecological endocrinology.
After getting his PhD in 1992, he worked as a medical assistant in internal medicine, oncology, cardiology, gastroenterology, and infectiology for several years.
Dr. Schwarzbach developed the first Radioimmunoassay (RIA) for human Gastric Inhibitory Polypeptide (hGIP) from 1986-1991 worldwide.
He began his studies of biochemistry (Hoechst AG, Frankfurt am Main/Germany) and pharmacy (University of Mainz/Germany) in 1984. After his degrees, he studied medicine for six years at the University of Mainz/Germany and finished his MD in 1991.